PARSIPPANY, N.J., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today issued the following statement regarding the U.S. Food and ...

The global safety syringes market, valued at approximately USD 7.1 billion in 2022, is projected to grow at a steady compound annual growth rate (CAGR) of over 4.5% during the forecast period from ...

People with type 1 diabetes, and occasionally those with type 2 diabetes, need to take insulin to maintain blood sugar levels. Insulin can be given in different ways: syringe, pen , or pump.

There are approximately 425 million people worldwide with diabetes. Approximately 75 million of these inject themselves with insulin daily. Now they may soon have a new alternative to syringes or ...